Denali Therapeutics Inc.
DNLI • NASDAQ
Denali Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan J. Watts, with a market cap of $2.9B.
CEORyan J. Watts
Next Earnings
Upcoming earnings announcement for Denali Therapeutics Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.71
Revenue Estimate
$13.2M
Earnings History
Past 12 earnings reports for Denali Therapeutics Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.73Est: -$0.75 | +2.7% | -Est: $9.0M | -100.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.74Est: -$0.76 | +2.6% | -Est: $6.2M | -100.0% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.72Est: -$0.74 | +2.7% | -Est: $13.4M | -100.0% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.78Est: -$0.71 | -9.9% | -Est: $3.2M | -100.0% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.67Est: -$0.91 | +26.4% | -Est: $12.6M | -100.0% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.63Est: -$0.61 | -3.3% | -Est: $9.5M | -100.0% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.59Est: -$0.68 | +13.2% | -Est: $15.0M | -100.0% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.68Est: -$0.70 | +2.9% | -Est: $14.0M | -100.0% | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$0.86Est: -$0.80 | -7.5% | -Est: $8.4M | -100.0% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.72Est: -$0.82 | +12.2% | $1.3MEst: $10.8M | -88.3% | — |
| Aug 8, 2023 | Q2 2023 | $1.30Est: -$0.68 | +291.2% | $294.1MEst: $13.5M | +2085.2% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.80Est: -$0.70 | -14.3% | $35.1MEst: $28.7M | +22.4% | — |